All other professional, scientific and technical activities n.e.c.
PHARMALEX NORWAY AS
Revenue 2025
NOK 20.6m
Operating profit
NOK −3.8m
Equity
NOK −329,000
Incorporated
2004
Employees
13
Share capital
NOK 100,000
Key figures · 2025
Current ratio
1.88
Equity ratio
-3.3%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -18.5% | |
| Net margin (%%) | -19.5% | |
| Return on assets (%%) | -38.4% | |
| Likviditet | ||
| Current ratio | 1.88 | |
| Working capital | 4.6m | |
| Soliditet | ||
| Equity ratio (%%) | -3.3% | |
| Debt-to-equity ratio | -31.15 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.